ER 50891 quarterhydrate is a potent RARalpha (retinoic acid receptor alpha) antagonist that significantly reduces the inhibitory effects of ATRA (all-trans retinoic acid) on BMP 2 (bone morphogenetic protein 2)-induced osteoblastogenesis [1].
Molecular Weight:
437.02
Formula:
C29H24N2O2.1/4H2O
Target:
Others|||Retinoid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted